Reversal Health publishes five-year outcomes in JMIR
A long-term follow-up of the reversal cohort shows durable improvements in glycemic control, weight, and cardiovascular markers.
Press releases, research announcements, and in-depth guides from the Reversal Health clinical and communications teams.
A long-term follow-up of the reversal cohort shows durable improvements in glycemic control, weight, and cardiovascular markers.
Beginning in Q3, members of a top-five U.S. health plan will have access at zero copay through their primary care provider.
Clinical data on more than 2,400 members who successfully tapered GLP-1 medications while maintaining weight loss.
A 22-page guide for HR and total rewards teams evaluating metabolic health vendors in 2026.
Recognizing companies addressing complex global health challenges with measurable results.
Subgroup analysis showing consistent outcomes across age, race, ethnicity, and social determinants.
Logos, leadership bios, outcomes summaries, and interview availability. Response time under 24 hours for press inquiries.